National Cancer Centre Singapore (NCCS)

Hospital


Location: , Singapore (SG) SG

ISNI: 0000000406209745

ROR: https://ror.org/03bqk3e80

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

HRQoL with neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Results from KEYNOTE-522 (2022) Dent RA, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation (2022) Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, et al. Journal article Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey (2022) Morita T, Kawahara T, Stone P, Sykes N, Miccinesi G, Klein C, Stiel S, et al. Journal article Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) A Systematic Review and Delphi Consensus Statement (2022) Pijnappel EN, Suurmeijer JA, Koerkamp BG, Kos M, Siveke JT, Salvia R, Ghaneh P, et al. Journal article, Review article Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Physicians' Opinion and Practice With the Continuous Use of Sedatives in the Last Days of Life (2021) Heijltjes MT, Morita T, Mori M, Heckel M, Klein C, Stiel S, Miccinesi G, et al. Journal article Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019) Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, et al. Journal article Exploring the complex etiology of oncogenic fusions in childhood cancer (2019) Anderson ND, De Borja R, Young MD, Fuligni F, Rosic A, Roberts ND, Pillay N, et al. Conference contribution Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3 (2018) Lim J, Park JH, Baude A, Fellenberg J, Zustin J, Haller F, Kruecken I, et al. Journal article